| SpectraBase Spectrum ID |
JIqHQblCHaK |
| Name |
1,4-Di-(2-chlorobenzyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
334.100354052 u |
| Formula |
C18H20Cl2N2 |
| InChI |
InChI=1S/C18H20Cl2N2/c19-17-7-3-1-5-15(17)13-21-9-11-22(12-10-21)14-16-6-2-4-8-18(16)20/h1-8H,9-14H2 |
| InChIKey |
MMCVUBRKOSEOKU-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
335.278 g/mol |
| Nominal Mass |
334 u |
| Quality |
985 |
| Retention Index |
2565 |
| SMILES |
C=1(C(=CC=CC1)Cl)CN1CCN(CC=2C(=CC=CC2)Cl)CC1 |
| SPLASH |
splash10-004i-2920000000-74a13d18c9c023a8d00e |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1,4-di-(2-chlorobenzyl)
1,4-bis(2-chlorobenzyl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011159 |
